Evidence map›Paper›PMID 37919332›Full record

ReviewNPJ Parkinson's disease2023

Overview on wearable sensors for the management of Parkinson's disease.

Caroline Moreau, Tiphaine Rouaud, David Grabli, Isabelle Benatru, Philippe Remy, Ana-Raquel Marques, Sophie Drapier, Louise-Laure Mariani, Emmanuel Roze, David Devos and 3 more

Abstract readReview
In one paragraph

Review in NPJ Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review.Movement disorders : official journal of the Movement Disorder Society · 2025
    Pooled it
  5. Pooled it
  6. Clinical trials in late-stage Parkinson's disease.Journal of Parkinson's disease · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Caroline MoreauDepartment of Neurology, Parkinson's disease expert Center, Lille University, INSERM UMRS_1172, University Hospital Center, Lille, France.
Tiphaine RouaudThe French Ns-Park Network, Paris, France.
David GrabliThe French Ns-Park Network, Paris, France.
Isabelle BenatruThe French Ns-Park Network, Paris, France.
Philippe RemyThe French Ns-Park Network, Paris, France.
Ana-Raquel MarquesThe French Ns-Park Network, Paris, France.ORCID http://orcid.org/0000-0003-2428-4899
Sophie DrapierThe French Ns-Park Network, Paris, France.
Louise-Laure MarianiThe French Ns-Park Network, Paris, France.ORCID http://orcid.org/0000-0002-2365-1223
Emmanuel RozeThe French Ns-Park Network, Paris, France.
David DevosThe French Ns-Park Network, Paris, France.
Gwendoline DupontThe French Ns-Park Network, Paris, France.ORCID http://orcid.org/0000-0002-5160-3800
Matthieu BereauThe French Ns-Park Network, Paris, France.
Margherita FabbriThe French Ns-Park Network, Paris, France. margheritafabbrimd@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is affecting about 1.2 million patients in Europe with a prevalence that is expected to have an exponential increment, in the next decades. This epidemiological evolution will be challenged by the low number of neurologists able to deliver expert care for PD. As PD is better recognized, there is an increasing demand from patients for rigorous control of their symptoms and for therapeutic education. In addition, the highly variable nature of symtoms between patients and the fluctuations within the same patient requires innovative tools to help doctors and patients monitor the disease in their usual living environment and adapt treatment in a more relevant way. Nowadays, there are various body-worn sensors (BWS) proposed to monitor parkinsonian clinical features, such as motor fluctuations, dyskinesia, tremor, bradykinesia, freezing of gait (FoG) or gait disturbances. BWS have been used as add-on tool for patients' management or research purpose. Here, we propose a practical anthology, summarizing the characteristics of the most used BWS for PD patients in Europe, focusing on their role as tools to improve treatment management. Consideration regarding the use of technology to monitor non-motor features is also included. BWS obviously offer new opportunities for improving management strategy in PD but their precise scope of use in daily routine care should be clarified.

Identifiers

PMID37919332
PMCPMC10622581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.